Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
October 15, 2018
Glenmark Pharmaceuticals Inducted into the Dow Jones Sustainability Indices (DJSI) Emerging Markets 2018, One of the Most Prestigious Global Sustainability Benchmarks
September 19, 2018
September 17, 2018
Glenmark Pharmaceuticals Announces FDA Acceptance of the Company’s First New Drug Application for Ryaltris™ for Patients with Seasonal Allergic Rhinitis
August 7, 2018
Glenmark Pharmaceuticals and Harbour BioMed Sign Agreement for Greater China to Develop GBR 1302, a First-in-Class Bispecific Antibody for Treatment of HER2-Positive Cancers
August 6, 2018
US Media Contact
For media inquiries only, please contact An Phan, Corporate Communications.
For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.